Axsome Therapeutics, Inc. (AXSM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.09B |
| Enterprise Value | 9B |
| P/E Ratio | -45.03 |
| PEG Ratio | -1.58 |
| Price/Sales Ratio | 11.19 |
| Price/Book Ratio | 104.39 |
| Enterprise/Revenue | 11.06 |
| Enterprise/EBITDA | -47.77 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.25 |
| Operating Margin | -0.24 |
AD
Management Effectiveness
| Return On Assets | -0.25 |
| Return On Equity | -2.56 |
Income Statement
| Revenue | 638.5M |
| Revenue/Share | 15.08 |
| Gross Profit | 591.02M |
| EBITDA | -168.08M |
| Net Income | -183.17M |
| Diluted EPS | -3.68 |
Balance Sheet
| Total Cash | 319.85M |
| Total Cash/Share | 6.21 |
| Total Debt | 219.21M |
| Total Debt/Equity | 2.63 |
| Current Ratio | 1.43 |
| Book Value Per Share | 1.62 |
Price History
| 52-Week Change | 42.25 |
| 52-Week High | 260.19 |
| 52-Week Low | 118.71 |
| Moving Average 50 Days | 205.63 |
| Moving Average 200 Days | 200.2 |
Statistics
| Average Volume | 705,243 |
| Shares Outstanding | 51.46M |
| % Held by Institutions | 75.3 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
